木利替尼

Mubritinib (TAK 165) (订货以英文为准)

编号:M129797
CAS号:366017-09-6
分子式:C25H23F3N4O2
分子量:468.47
货号 品牌 包装 目录价 您的价格 库存 数量 购买
M129797-50mg 阿拉丁 50mg ¥1628.90
M129797-10mg 阿拉丁 10mg ¥415.90
M129797-250mg 阿拉丁 250mg ¥6179.90
产品名称 Mubritinib (TAK 165)
中文名称 木利替尼
CAS号 366017-09-6
分子式(M.F.) C25H23F3N4O2
分子量(M.W.) 468.47
储存条件 -20°C储存
熔点154-166 oC
溶解性Soluble in DMSO (25 mg/mL) with warming; ethanol (1.7 mg/mL), and water (<1 mg/mL).
存贮条件储存温度-20°C
应用A selective, potent, and irreversible ErbB2 and EGFR inhibitor.
产品介绍Mubritinib (TAK 165)是一种有效的HER2/ErbB2抑制剂,IC50为6 nM;对EGFR, FGFR, PDGFR, JAK1, Src和Blk没有抑制活性。
备注Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM; no activity to EGFR, FGFR, PDGFR, JAK1, Src and Blk.
生化机理TAK 165 is a potent Neu (HER2) and Cdc2 p34 inhibitor with IC50 of 6 nM and 0.2μM, respectively. TAK 165 also inhibits Cdk2 (p33cdk2) and Cdk5 (p33cdk5). TAK 165 displays > 4000-fold selectivity over EGFR, FGFR, PDGFR, JAK1 and Src. TAK 165 exhibits potent antiproliferative effects in Neu-overexpressing cancer cell lines (IC50 = 5 nM in BT474 breast cancer cells) and significantly inhibits bladder, breast and prostate cancer xenograft growth.
别名TAK 165;TAK165;木利替尼; 1-(4-(4-((2-((1E)-2-(4-(三氟甲基)苯基)乙烯基)-4-恶唑基)甲氧基)苯基)丁基)-1H-1,2,3-三氮唑;TAK 165; TAK165;1-(4-(4-((2-((1E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 100.00 sh-355541-1盒
CAS号:643-13-0
¥ 758.00 D875352-25mg
CAS号:10277-43-7
¥ 415.00 L812375-25g
CAS号:10125-13-0
¥ 230.00 C805301-5g
¥ 2280.00 05037891-1台
CAS号:18362-36-2
¥ 104.00 BD208955
CAS号:13463-67-7
¥ 32.00 M89334-25g